Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Desano Biopharmaceutical is a key subsidiary of Shanghai Desano Pharmaceuticals, specializing in the large-scale manufacturing of anti-viral and oncology medications. Located in the Chengdu Hi-tech Zone, the company operates advanced GMP-compliant facilities dedicated to the production of active pharmaceutical ingredients (APIs) and finished dosage forms. It plays a vital role in the global supply chain for HIV/AIDS treatments, providing high-quality, affordable generic antiretroviral drugs to international markets. The company's portfolio also includes treatments for Hepatitis B and C, as well as a growing pipeline of oncological therapies. Through its parent company, Chengdu Desano maintains significant collaborations with global health organizations like the Medicines Patent Pool and the World Health Organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Desano Biotech.